Accuray | ARAY - Equity Capital And Reserves


Accuray reported $53.42M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 450.47M 2.24M Mar/2026
AtriCure USD 491.69M 242K Mar/2026
Boston Scientific USD 25.86B 1.63B Mar/2026
Edwards Lifesciences USD 10.33B 10.1M Mar/2026
Inogen USD 197.18M 2.32M Sep/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 435.19M 14.85M Mar/2026
Surmodics USD 111.31M 7.59M Jun/2025
Tandem Diabetes Care USD 132.4M 22.77M Mar/2026
Trinity Biotech USD -54.72M 5.18M Sep/2025